Search
Menu
BAE Systems Sensor Solutions - Fairchild - Thermal Imaging Solutions 4/24 LB

Fox Chase Cancer Center

Facebook X LinkedIn Email
Fox Chase Cancer Center of Philadelphia and VisEn Medical Inc. of Woburn, Mass., have partnered to advance the Phase I clinical trials of the company’s “smart” fluorescence-activatable imaging agents, which they hope will enable physicians to identify and characterize early-stage disease in oncology patients. The trials initially will focus on ovarian cancer and are scheduled to begin in 2009.Read full article

Related content from Photonics Media



    Articles


    Products


    Photonics Handbook Articles


    White Papers


    Webinars


    Photonics Dictionary Terms


    Media


    Photonics Buyers' Guide Categories


    Companies
    Published: August 2008
    BiophotonicsflourescenceFox Chase Cancer CenterImagingNews & Features

    We use cookies to improve user experience and analyze our website traffic as stated in our Privacy Policy. By using this website, you agree to the use of cookies unless you have disabled them.